TherapeuticsMD, Inc. (TXMD) Financials

TXMD Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 42.1 million 13.4 million
2023-12-31 43.3 million 14.0 million
2023-09-30 50.5 million 22.4 million
2023-06-30 53.7 million 22.5 million

TXMD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 11000 111000
2023-12-31 -7.8 million 116000
2023-09-30 -6.0 million 234000
2023-06-30 -3.4 million 438000

TXMD Net Income

No data available :(

TXMD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 4.3 million - 7.8 million
2023-12-31 4.3 million - -
2023-09-30 10.2 million - 8.2 million
2023-06-30 13.7 million - 8.4 million

TXMD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 11.5 million
2023-12-31 11.5 million
2023-09-30 10.7 million
2023-06-30 10.2 million

TXMD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 - - 1.3 million -
2023-12-31 - - 3.1 million 1.6 million
2023-09-30 - - 1.6 million -
2023-06-30 10000 - 2.8 million -

TXMD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 313000 133000
2023-12-31 502000 637000
2023-09-30 -53000 130000
2023-06-30 437000 128000

TXMD

Price: $2.13

52 week price:
1.84
4.52

Earnings Per Share: -0.74 USD

P/E Ratio: 0.46

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 688

Ebitda: -21.6 million

Market Capitalization: 25.6 million

Links: